Riccardo Lencioni

Summary

Affiliation: University of Pisa
Country: Italy

Publications

  1. doi request reprint Transarterial treatment of colorectal cancer liver metastases with irinotecan-loaded drug-eluting beads: technical recommendations
    Riccardo Lencioni
    Division of Diagnostic Imaging and Intervention, Pisa University School of Medicine, Pisa, Italy Electronic address
    J Vasc Interv Radiol 25:365-9. 2014
  2. doi request reprint New data supporting modified RECIST (mRECIST) for Hepatocellular Carcinoma
    Riccardo Lencioni
    Division of Diagnostic Imaging and Intervention, Pisa University School of Medicine, Pisa, Italy
    Clin Cancer Res 19:1312-4. 2013
  3. doi request reprint Chemoembolization for hepatocellular carcinoma
    Riccardo Lencioni
    Division of Diagnostic Imaging and Intervention, Pisa University School of Medicine, Pisa, Italy
    Semin Oncol 39:503-9. 2012
  4. pmc Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): technical recommendations
    Riccardo Lencioni
    Pisa University Hospital, University of Pisa, Pisa, IT, Italy
    Cardiovasc Intervent Radiol 35:980-5. 2012
  5. doi request reprint Image-guided ablation for hepatocellular carcinoma
    Riccardo Lencioni
    Division of Diagnostic Imaging and Intervention, Pisa University School of Medicine, Pisa, Italy
    Recent Results Cancer Res 190:181-94. 2013
  6. doi request reprint First interim analysis of the GIDEON (Global Investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafeNib) non-interventional study
    R Lencioni
    Division of Diagnostic Imaging and Intervention, Pisa University Hospital and School of Medicine, Pisa, Italy
    Int J Clin Pract 66:675-83. 2012
  7. doi request reprint Local-regional treatment of hepatocellular carcinoma
    Riccardo Lencioni
    Division of Diagnostic Imaging and Intervention, Department of Liver Transplantation, Hepatology, and Infectious Diseases, Pisa University Hospital, Via Paradisa 2, 56124 Pisa, Italy
    Radiology 262:43-58. 2012
  8. ncbi request reprint Clinical management of hepatic malignancies: ferucarbotran-enhanced magnetic resonance imaging versus contrast-enhanced spiral computed tomography
    Riccardo Lencioni
    Department of Radiology, University of Pisa, Pisa, Italy
    Dig Dis Sci 50:533-7. 2005
  9. doi request reprint Thermal ablation of lung tissue: in vivo experimental comparison of microwave and radiofrequency
    Laura Crocetti
    Division of Radiodiagnostic, Department of Oncological and Radiological Sciences, Pisa University Hospital, Pisa, Italy
    Cardiovasc Intervent Radiol 33:818-27. 2010
  10. doi request reprint Loco-regional interventional treatment of hepatocellular carcinoma: techniques, outcomes, and future prospects
    Riccardo Lencioni
    Division of Diagnostic Imaging and Intervention, Department of Liver Transplantation, Pisa University Hospital and School of Medicine, Pisa, Italy
    Transpl Int 23:698-703. 2010

Detail Information

Publications46

  1. doi request reprint Transarterial treatment of colorectal cancer liver metastases with irinotecan-loaded drug-eluting beads: technical recommendations
    Riccardo Lencioni
    Division of Diagnostic Imaging and Intervention, Pisa University School of Medicine, Pisa, Italy Electronic address
    J Vasc Interv Radiol 25:365-9. 2014
    ..The present article provides a set of technical recommendations for the use of DEBIRI in the treatment of hepatic CRC metastases. ..
  2. doi request reprint New data supporting modified RECIST (mRECIST) for Hepatocellular Carcinoma
    Riccardo Lencioni
    Division of Diagnostic Imaging and Intervention, Pisa University School of Medicine, Pisa, Italy
    Clin Cancer Res 19:1312-4. 2013
    ..A growing amount of data suggests that mRECIST, designed for response assessment in clinical trials, may translate into a tool for clinical practice...
  3. doi request reprint Chemoembolization for hepatocellular carcinoma
    Riccardo Lencioni
    Division of Diagnostic Imaging and Intervention, Pisa University School of Medicine, Pisa, Italy
    Semin Oncol 39:503-9. 2012
    ..These data support the further evaluation of molecular targeted, systemically active agents in combination with DEB-TACE in a phase III setting...
  4. pmc Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): technical recommendations
    Riccardo Lencioni
    Pisa University Hospital, University of Pisa, Pisa, IT, Italy
    Cardiovasc Intervent Radiol 35:980-5. 2012
    ..The conclusions of the expert panel are summarized...
  5. doi request reprint Image-guided ablation for hepatocellular carcinoma
    Riccardo Lencioni
    Division of Diagnostic Imaging and Intervention, Pisa University School of Medicine, Pisa, Italy
    Recent Results Cancer Res 190:181-94. 2013
    ....
  6. doi request reprint First interim analysis of the GIDEON (Global Investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafeNib) non-interventional study
    R Lencioni
    Division of Diagnostic Imaging and Intervention, Pisa University Hospital and School of Medicine, Pisa, Italy
    Int J Clin Pract 66:675-83. 2012
    ....
  7. doi request reprint Local-regional treatment of hepatocellular carcinoma
    Riccardo Lencioni
    Division of Diagnostic Imaging and Intervention, Department of Liver Transplantation, Hepatology, and Infectious Diseases, Pisa University Hospital, Via Paradisa 2, 56124 Pisa, Italy
    Radiology 262:43-58. 2012
    ....
  8. ncbi request reprint Clinical management of hepatic malignancies: ferucarbotran-enhanced magnetic resonance imaging versus contrast-enhanced spiral computed tomography
    Riccardo Lencioni
    Department of Radiology, University of Pisa, Pisa, Italy
    Dig Dis Sci 50:533-7. 2005
    ..0167). Ferucarbotran-enhanced MR imaging is superior to spiral CT in clinical management of patients with suspected hepatic malignancy...
  9. doi request reprint Thermal ablation of lung tissue: in vivo experimental comparison of microwave and radiofrequency
    Laura Crocetti
    Division of Radiodiagnostic, Department of Oncological and Radiological Sciences, Pisa University Hospital, Pisa, Italy
    Cardiovasc Intervent Radiol 33:818-27. 2010
    ..Feasibility and safety of MW and RF ablation are similar in a lung rabbit model. MW ablation produces a greater damage to peripheral small vessels inducing thrombosis...
  10. doi request reprint Loco-regional interventional treatment of hepatocellular carcinoma: techniques, outcomes, and future prospects
    Riccardo Lencioni
    Division of Diagnostic Imaging and Intervention, Department of Liver Transplantation, Pisa University Hospital and School of Medicine, Pisa, Italy
    Transpl Int 23:698-703. 2010
    ..Clinical trials focused on combining interventional treatment with systemically active drugs are ongoing. The outcomes of such studies are eagerly awaited, as they have the potential to revolutionize treatment of HCC...
  11. doi request reprint Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study
    Riccardo Lencioni
    Division of Diagnostic and Interventional Radiology, Department of Oncology and Radiology, Cisanello University Hospital Building No 9, Via Paradisa 2, IT 56124 Pisa, Italy
    J Hepatol 49:217-22. 2008
    ..We aimed to assess safety and efficacy of doxorubicin-eluting bead (DEB)-enhanced RF ablation in the treatment of human hepatocellular carcinoma (HCC)...
  12. pmc Thermal ablation of hepatocellular carcinoma
    Laura Crocetti
    Division of Diagnostic and Interventional Radiology, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, Pisa, Italy
    Cancer Imaging 8:19-26. 2008
    ....
  13. ncbi request reprint Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation
    Riccardo Lencioni
    Division of Diagnostic and Interventional Radiology, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, Via Roma 67, I 56125 Pisa, Italy
    Radiology 234:961-7. 2005
    ....
  14. ncbi request reprint A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma
    Riccardo Lencioni
    Division of Diagnostic and Interventional Radiology, Department of Oncology, Transplants, and Advanced Technologies in Medicine, University of Pisa, Via Roma 67, Pisa I 56125, Italy
    Clin Liver Dis 9:301-14, viii. 2005
    ..Further randomized trials are needed to establish the clinical efficacy of radiofrequency ablation with respect to other percutaneous treatments and to devise an unbiased therapeutic strategy...
  15. ncbi request reprint Targeting liver lesions for radiofrequency ablation: an experimental feasibility study using a CT-US fusion imaging system
    Laura Crocetti
    Division of Diagnostic and Interventional Radiology, Department of Oncology, Transplant and Advanced Technologies in Medicine, University of Pisa, Pisa, Italy
    Invest Radiol 43:33-9. 2008
    ....
  16. pmc Quality improvement guidelines for radiofrequency ablation of liver tumours
    Laura Crocetti
    Division of Diagnostic Imaging and Intervention, Department of Hepatology, Liver Transplants, and Infectious Diseases, University of Pisa, Pisa, Italy
    Cardiovasc Intervent Radiol 33:11-7. 2010
    ..The most important processes of care are (1) patient selection, (2) performing the procedure, and (3) monitoring the patient. The outcome measures or indicators for these processes are indications, success rates, and complication rates...
  17. ncbi request reprint Clinical management of focal liver lesions: the key role of real-time contrast-enhanced US
    Riccardo Lencioni
    Division of Diagnostic and Interventional Radiology, Department of Oncology, Transplants, and Advanced Technologies in Medicine, University of Pisa, Italy
    Eur Radiol 17:F73-9. 2007
    ....
  18. doi request reprint Percutaneous image-guided radiofrequency ablation of liver tumors
    Riccardo Lencioni
    Department of Hepatology and Liver Transplantation, Pisa University Hospital, Italy
    Abdom Imaging 34:547-56. 2009
    ..In this article, we review technique, indications, and clinical results of percutaneous RF ablation in the treatment of HCC and colorectal hepatic metastases...
  19. doi request reprint Single-session percutaneous ethanol ablation of early-stage hepatocellular carcinoma with a multipronged injection needle: results of a pilot clinical study
    Riccardo Lencioni
    Division of Diagnostic Imaging and Intervention, Department of Liver Transplantation, Cisanello University Hospital, Building No 30C, Via Paradisa 2, IT 56124, Pisa, Italy
    J Vasc Interv Radiol 21:1533-8. 2010
    ..To investigate the feasibility, safety, and efficacy of single-session ethanol ablation with multipronged needles in the treatment of early-stage hepatocellular carcinoma (HCC)...
  20. doi request reprint Management of hepatocellular carcinoma with transarterial chemoembolization in the era of systemic targeted therapy
    Riccardo Lencioni
    Division of Diagnostic Imaging and Intervention, Department of Hepatology and Liver Transplantation, Pisa University Hospital, Via Paradisa 2, Building No 29, Pisa 56124, Italy
    Crit Rev Oncol Hematol 83:216-24. 2012
    ..The synergistic combination of TACE plus sorafenib represents a promising opportunity for tumor control...
  21. ncbi request reprint Radiofrequency ablation of liver cancer
    Riccardo Lencioni
    Division of Diagnostic and Interventional Radiology, Department of Oncology, Transplants, and Advanced Technologies in Medicine, University of Pisa, Pisa, Italy
    Tech Vasc Interv Radiol 10:38-46. 2007
    ..In this article, we review technique, indications, and clinical results of percutaneous RF ablation in the treatment of HCC and colorectal hepatic metastases...
  22. doi request reprint Image-guided thermal ablation of hepatocellular carcinoma
    Riccardo Lencioni
    Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, Pisa, Italy
    Crit Rev Oncol Hematol 66:200-7. 2008
    ....
  23. doi request reprint Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?
    Riccardo Lencioni
    Division of Diagnostic Imaging and Intervention, Department of Liver Transplantation, Hepatology, and Infectious Diseases, Pisa University School of Medicine, Cisanello Hospital, Pisa, Italy
    Oncologist 15:42-52. 2010
    ..It is hoped that findings from the GIDEON study along with phase III RCT data will lead to better outcomes for patients with intermediate-advanced HCC...
  24. ncbi request reprint Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results, and new promises
    Riccardo Lencioni
    Division of Diagnostic and Interventional Radiology, Department of Oncology, Transplants, and Advanced Technologies in Medicine, University of Pisa, Pisa, Italy
    Invest Radiol 39:689-97. 2004
    ..In this article, we review technique, indications, clinical results, and future prospects of RF ablation in the therapeutic management of metastatic colorectal cancer patients...
  25. ncbi request reprint Imaging diagnosis
    Riccardo Lencioni
    Division of Diagnostic and Interventional Radiology, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, I 56125 Pisa, Italy
    Semin Liver Dis 25:162-70. 2005
    ..These examinations have replaced invasive procedures, such as lipiodol CT, but remain relatively insensitive for the detection of tiny HCC lesions and tumor vascular invasion into peripheral portal vein branches...
  26. doi request reprint Lung radiofrequency ablation: in vivo experimental study with low-perfusion-rate multitined electrodes
    Laura Crocetti
    Division of Diagnostic and Interventional Radiology, Department of Oncology, Transplant and Advanced Technologies in Medicine, University of Pisa, Via Roma 67, I 56125 Pisa, Italy
    Cardiovasc Intervent Radiol 31:610-8. 2008
    ..In conclusion, lung RF ablation performed in an in vivo animal model using low-perfusion-rate, expandable, multitined electrodes is feasible and safe. No severe damage to adjacent structures was demonstrated...
  27. doi request reprint Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study)
    Riccardo Lencioni
    Division of Diagnostic and Interventional Radiology, Department of Oncology, Transplants, and Advanced Technologies in Medicine, University of Pisa, Pisa, Italy
    Lancet Oncol 9:621-8. 2008
    ..The purpose of this study was to identify the feasibility, safety, and effectiveness of percutaneous radiofrequency ablation of malignant lung tumours...
  28. doi request reprint Guidelines for imaging focal lesions in liver cirrhosis
    Riccardo Lencioni
    Division of Diagnostic and Interventional Radiology, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, Via Roma 67, IT 56126, Pisa, Italy
    Expert Rev Gastroenterol Hepatol 2:697-703. 2008
    ..However, even optimized imaging techniques remain relatively insensitive for the detection of tiny satellite nodules associated with the main tumor...
  29. ncbi request reprint Percutaneous ablation of hepatocellular carcinoma: state-of-the-art
    Riccardo Lencioni
    Division of Diagnostic and Interventional Radiology, Department of Oncology, Transplants, and Advanced Technologies in Medicine, University of Pisa, Italy
    Liver Transpl 10:S91-7. 2004
    ..Further investigation is warranted to clarify whether current RF technology could offer improved results in patients with intermediate-stage HCC...
  30. doi request reprint Modified RECIST (mRECIST) assessment for hepatocellular carcinoma
    Riccardo Lencioni
    Division of Diagnostic Imaging and Intervention, Department of Liver Transplantation, Hepatology, and Infectious Diseases, University of Pisa, Pisa, Italy
    Semin Liver Dis 30:52-60. 2010
    ..They are referred to herein as the modified RECIST assessment (mRECIST). Further studies are needed to confirm the accuracy of this measurement compared with conventional gold standards such as pathologic studies of explanted livers...
  31. ncbi request reprint Percutaneous ablation of hepatocellular carcinoma
    Riccardo Lencioni
    Division of Diagnostic and Interventional Radiology, University of Pisa, Rome, Italy
    Recent Results Cancer Res 167:91-105. 2006
  32. doi request reprint Surveillance and early diagnosis of hepatocellular carcinoma
    Riccardo Lencioni
    Division of Diagnostic Imaging and Intervention, Department of Liver Transplantation, Hepatology and Infectious Diseases, University of Pisa, Pisa, Italy
    Dig Liver Dis 42:S223-7. 2010
    ..If the biopsy is negative for HCC, patients should be followed-up by imaging studies performed at 3-month intervals until the nodule either disappears, enlarges, or displays diagnostic characteristics of HCC...
  33. doi request reprint Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma
    Riccardo Lencioni
    Division of Diagnostic and Interventional Radiology, Department of Oncology, Transplants, and Advanced Technologies in Medicine, Cisanello University Hospital, Via Paradisa 2, University of Pisa, Pisa, Italy
    J Hepatol 48:848-57. 2008
    ..Hence, CT or MR imaging are still mandatory for proper intrahepatic staging of the disease...
  34. ncbi request reprint Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media
    Carlo Bartolozzi
    Division of Diagnostic and Interventional Radiology, Department of Oncology, Transplant and Advanced Technologies in Medicine, University of Pisa, Via Roma 67, 56125, Pisa, Italy
    Eur Radiol 17:2519-30. 2007
    ....
  35. doi request reprint Peri-intraprocedural imaging: US, CT, and MRI
    Laura Crocetti
    Division of Diagnostic Imaging and Intervention, Department of Liver Transplants, Hepatology and Infectious Diseases, Cisanello Hospital, Pisa University School of Medicine, Building No 29, Via Paradisa 2, 56124, Pisa, Italy
    Abdom Imaging 36:648-60. 2011
    ..Recently amended RECIST (mRECIST) for evaluation of tumor response in hepatocellular carcinoma and specific treatment-related findings after thermal ablation, trans-arterial chemoembolization, and radioembolization will be reviewed...
  36. doi request reprint Hepatocellular carcinoma: new options for image-guided ablation
    Riccardo Lencioni
    Division of Diagnostic Imaging and Intervention, Department of Liver Transplantation, Hepatology, and Infectious Diseases, Pisa University School of Medicine, Cisanello Hospital, Building 30C, Suite 197, 56124 Pisa, Italy
    J Hepatobiliary Pancreat Sci 17:399-403. 2010
    ....
  37. doi request reprint Loco-regional treatment of hepatocellular carcinoma in the era of molecular targeted therapies
    Riccardo Lencioni
    Division of Diagnostic Imaging and Intervention, Department of Liver Transplantation, Hepatology, and Infectious Diseases, Pisa University School of Medicine, Pisa, Italy
    Oncology 78:107-12. 2010
    ..Clinical trials focused on combining interventional treatment with systemically active drugs are ongoing. The outcomes of such studies are eagerly awaited, as they have the potential to revolutionize treatment of HCC...
  38. ncbi request reprint Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT
    Carlo Bartolozzi
    Department of Radiology, University of Pisa, Via Roma 67, 56100, Pisa, Italy
    Eur Radiol 14:14-20. 2004
    ..0023) and unenhanced MRI (21 of 44 cases, p=0.0013). MnDPDP-enhanced MRI is superior to unenhanced MRI and spiral CT in the detection of hepatic colorectal metastases...
  39. ncbi request reprint Clinical impact of Resovist-enhanced MRI: results of an Italian multicenter trial
    Riccardo Lencioni
    Oncology Department, Division of Diagnostic and Interventional Radiology, University of Pisa, Via Roma 67, 56126 Pisa, Italy
    Eur Radiol 14:C10. 2004
  40. doi request reprint Contrast-induced nephropathy in patients undergoing computed tomography (CONNECT) - a clinical problem in daily practice? A multicenter observational study
    Riccardo Lencioni
    Department of Liver Transplantation, Hepatology, and Infectious Diseases, Pisa University Hospital, Italy
    Acta Radiol 51:741-50. 2010
    ....
  41. doi request reprint Radiofrequency ablation of pulmonary tumors
    Laura Crocetti
    Division of Diagnostic Imaging and Intervention, Department of Liver Transplants, Hepatology and Infectious Diseases, Pisa University School of Medicine, Italy
    Eur J Radiol 75:23-7. 2010
    ....
  42. ncbi request reprint European federation of societies for ultrasound in medicine and biology (EFSUMB) guidelines for the use of contrast agents in liver ultrasound: what is the impact in clinical practice?
    Riccardo Lencioni
    Division of Diagnostic and Interventional Radiology, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, Via Roma 67, IT 56126 Pisa, Italy
    Eur Radiol 15:E98-103. 2005
    ....
  43. ncbi request reprint Radiofrequency ablation of lung malignancies: where do we stand?
    Riccardo Lencioni
    Division of Diagnostic and Interventional Radiology, Department of Oncology, Transplants, and Advanced Technologies in Medicine, University of Pisa, Via Roma 67, I 56126, Pisa, Italy
    Cardiovasc Intervent Radiol 27:581-90. 2004
    ..This article gives an overview of lung RF ablation, discussing experimental animal findings, rationale for clinical application, technique and methodology, clinical results, and complications...
  44. doi request reprint Loco-regional treatment of hepatocellular carcinoma
    Riccardo Lencioni
    Division of Diagnostic Imaging and Intervention, Department of Liver Transplantation, Hepatology, and Infectious Diseases, Pisa University Hospital, Pisa, Italy
    Hepatology 52:762-73. 2010
    ..The outcomes of these trials are eagerly awaited, because they have the potential to revolutionize the treatment of HCC...
  45. ncbi request reprint Impact of European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) guidelines on the use of contrast agents in liver ultrasound
    Riccardo Lencioni
    Division of Diagnostic and Interventional Radiology, Department of Oncology, Transplants, and Advanced Technologies in Medicine, University of Pisa, Via Roma 67, 56126, Pisa, Italy
    Eur Radiol 16:1610-3. 2006
    ..We discuss the impact of EFSUMB guidelines on diagnostic protocols currently adopted in liver imaging...
  46. ncbi request reprint Magnetic resonance imaging of liver tumors
    Riccardo Lencioni
    Division of Diagnostic and Interventional Radiology, Department of Oncology, Transplants, and Advanced Technologies in Medicine, University of Pisa, Via Roma 67, I 56126 Pisa, Italy
    J Hepatol 40:162-71. 2004